Medigus Ltd. (MDGS:NASDAQ) soared at $1.92, representing a gain of 28%. The stock got featured on our News Catalysts scanner on Fri, Jul 23, 2021 at 08:05 AM in the 'BIOTECH' category. From Thu, Jul 08, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Feb 09, 2021 at $3.77 with a volume of 7M+, and its share price has been moving sideways in recent weeks.
About Medigus Ltd. (MDGS:NASDAQ)
Medigus Ltd, together with its subsidiaries, is a medical device group engaged in research and development of endoscopic procedures and devices. Its product includes SRS endoscopy systems for the treatment of gastroesophageal reflux disease.
Top 10 Gainers:
- SKYA (SKYA:NASDAQ), 100%
- The New Home Company Inc. (NWHM:NYSE), 82.92%
- Veoneer, Inc. (VNE:NYSE), 56.4%
- NRXP (NRXP:NASDAQ), 50.58%
- Socket Mobile, Inc. (SCKT:NASDAQ), 43.97%
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 35.48%
- Medigus Ltd. (MDGS:NASDAQ), 28%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 24.15%
- ATA Creativity Global (AACG:NASDAQ), 24.02%